Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Consolidated Net Income (2024 - 2026)

Updated

Translational Development Acquisition's Consolidated Net Income came in at $983,120 for Q2 2026, down 39.4% from $1.62 million a year earlier and down 26.2% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Consolidated Net Income (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Translational Development Acquisition reported Consolidated Net Income of $5.45 million, up 79.3% year-over-year; for FY2025, it came in at $6.36 million.

  • Going back by year, Consolidated Net Income was -$71,012 in FY2024 and -$485,550 in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Consolidated Net Income since Q4 2024.
  • Business Quant data shows TDACU's Consolidated Net Income at $1.33 million (Q1 2026), $1.47 million (Q4 2025) and $1.66 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 983,120.00
Mar 31, 2026 1.33 Mn
Dec 31, 2025 1.47 Mn
Sep 30, 2025 1.66 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 -8,044.00
Sep 30, 2024 -61,283.00
Jun 30, 2024 -1,685.00
API Access

Translational Development Acquisition Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=TDACU&period=max&api_key=YOUR_API_KEY